15 BMS 1964 (Zerit 15 mg)
Generic Name: stavudine
Pill with imprint 15 BMS 1964 is Red / Yellow, Capsule-shape and has been identified as Zerit 15 mg. It is supplied by Bristol-Myers Squibb.
Zerit is used in the treatment of nonoccupational exposure; hiv infection and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). Risk cannot be ruled out during pregnancy. Zerit 15 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 15 BMS 1964
Zerit
- Generic Name
- stavudine
- Imprint
- 15 BMS 1964
- Strength
- 15 mg
- Color
- Red / Yellow
- Size
- 3.00 mm
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Nucleoside reverse transcriptase inhibitors (nrtis)
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Bristol-Myers Squibb
- Inactive Ingredients
-
microcrystalline cellulose,
sodium starch glycolate type A potato,
lactose,
magnesium stearate,
gelatin,
titanium dioxide
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 00003-1964 | |
| 54868-3360 | Physicians Total Care Inc. (repackager) |
More about Zerit (stavudine)
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- En Español
- Drug class: nucleoside reverse transcriptase inhibitors (NRTIs)
- FDA Alerts (1)
Consumer resources
- Patient Information
- Zerit (Advanced Reading)
- Zerit (Stavudine Capsules)
- Zerit (Stavudine Oral Solution)
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.